Frontlight ResearchEarly access
CompletedNo phase
TMS for Anxiety and Trauma-related Disorders
Key facts
- Who runs it
- Shanghai Mental Health Center
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 15 people enrolled
- Started
- 19 Jun 2024
- Ended
- 13 Apr 2025
- Type of study
- Interventional
- Treatments tested
- transcranial magnetic stimulation
- Record updated
- 24 June 2026
Who can take part
- Age
- 18 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Diagnosis of generalized anxiety disorder (GAD), social anxiety disorder (SAD), panic disorder (PD), and/or post-traumatic stress disorder (PTSD) as defined by DSM-5 criteria
- Male or female between 18 and 60 years old
- Right-handed
- Can understand and sign an informed consent document
- Beck Anxiety Inventory (BAI) score of 16 or higher
- On a stable medication/psychotherapy regimen for at least 6 weeks prior to baseline visit and throughout the duration of the study
- In good general health, as ascertained by medical history
- Pharmacological treatment resistance or psychotherapeutic treatment resistance
Who cannot take part
- Substance use disorders, eating disorders, significant suicidal ideation, mental disorder due to a medical or neurocognitive condition, lifetime psychosis, bipolar disorder, developmental disorders
- History of brain surgery and epilepsy
- Presence of metallic foreign bodies, such as cardiac pacemakers and stents
- Any medical condition or medication that increases the risk of seizures
- Current severe somatic disease, such as cancer, heart failure, pneumonia, etc
- Pregnancy
- Intellectual disability
- Severe claustrophobia that prevents the use of MRI
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The present pilot study will apply accelerated intermittent theta burst stimulation (aiTBS) to a novel transcranial magnetic stimulation (TMS) target for anxiety derived via causal network mapping.
The group in the trial
- Open-label aiTBS to novel right dmPFC TMS anxiety targetTreatment being tested
Treatment: transcranial magnetic stimulation
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Accelerated Intermittent Theta Burst Stimulation to a Novel DLPFC Target for Anxiety and Trauma-related Disorders: a Pilot Study
- Record updated
- 24 June 2026